Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist fo
about
A New Method to Stabilize C-Kit Expression in Reparative Cardiac Mesenchymal Cells.Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discoveryTransgenic overexpression of GTP cyclohydrolase 1 in cardiomyocytes ameliorates post-infarction cardiac remodeling.Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury.Widespread Intracoronary Cardiopoietic Cell Infusion: Treating at the Time of Myocardial Reperfusion to Prevent Rather Than Reverse Established Left Ventricular Dysfunction Moves Us Closer to Practical Clinical Translation.Fibronectin and Cyclic Strain Improve Cardiac Progenitor Cell Regenerative Potential In Vitro.miR-21 Reduces Hydrogen Peroxide-Induced Apoptosis in c-kit+ Cardiac Stem Cells In Vitro through PTEN/PI3K/Akt Signaling.Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.A Deep Proteome Analysis Identifies the Complete Secretome as the Functional Unit of Human Cardiac Progenitor Cells.Where Does Inflammation Fit?A collagen cardiac patch incorporating alginate microparticles permits the controlled release of hepatocyte growth factor and insulin-like growth factor-1 to enhance cardiac stem cell migration and proliferation.Roles of exosomes in cardioprotection.Innate heart regeneration: endogenous cellular sources and exogenous therapeutic amplification.The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away.The EAPC EXPERT tool.Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion InjuryRepeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell TherapyHistone Deacetylase 1 Depletion Activates Human Cardiac Mesenchymal Stromal Cell Proangiogenic Paracrine Signaling Through a Mechanism Requiring Enhanced Basic Fibroblast Growth Factor Synthesis and Secretion.Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of AdherencemiR-21 increases c-kit+ cardiac stem cell proliferation in vitro through PTEN/PI3K/Akt signaling.Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction.Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification.Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia.Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair.Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit+ Cells.Exosomes Mediate the Beneficial Effects of Exercise.Recombinant frizzled1 protein attenuated cardiac hypertrophy after myocardial infarction via the canonical Wnt signaling pathway.Bone marrow mesenchymal stem cell-derived exosomal miR-21 protects C-kit+ cardiac stem cells from oxidative injury through the PTEN/PI3K/Akt axis.Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose.Identity Crisis for Regenerative Cardiac cKit+ Cells.Repeated Cell Therapy: A Paradigm Shift Whose Time Has Come.Single-cell analysis of the fate of c-kit-positive bone marrow cells.The adaptive immune response to cardiac injury-the true roadblock to effective regenerative therapies?Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.By Targeting Atg7 MicroRNA-143 Mediates Oxidative Stress-Induced Autophagy of c-Kit+ Mouse Cardiac Progenitor Cells.New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic ImplicationsNew Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell TypesTwo mechanisms of cardiac stem cell-mediated cardiomyogenesis in the adult mammalian heart include formation of colonies and cell-in-cell structurescardiac regeneration by using neuropeptide substance P and IGF-1C peptide eluting heart patchesExosomes Derived from miR-214-Enriched Bone Marrow-Derived Mesenchymal Stem Cells Regulate Oxidative Damage in Cardiac Stem Cells by Targeting CaMKII
P2860
Q27330396-CE01ACFF-3DF0-450B-A079-12B4840858C1Q28073078-B3C8AFD5-98EC-47AF-98F6-91C7DD955DBCQ33780119-8B6161B5-F2F3-4902-BE1E-448146E4B432Q36314795-FEDC5175-1129-4EB9-8FFF-0BC5AF050A67Q36760792-A7FC18EA-2967-4E69-A660-BEA5617BE5D7Q37215366-95375A87-4378-4519-87E1-673AFEC165DDQ37359807-21C22D47-7AAE-4562-AB6A-1BB68AD9CF10Q37602004-F69F68E2-D577-4AB9-BCE4-9710EB9E1A6EQ38289941-538C4CF6-2C47-49B1-B581-80904124A7B0Q38639570-93FCB5A6-00C0-40AC-9387-C62E4FC242C3Q38783994-43D39236-B3D1-40BB-969F-8ADA1D79920CQ38904719-3B3BE84D-93FB-4A17-B65E-0DFEBE8A5859Q38916204-16829246-24B8-4130-8C96-1CFAEF1691C9Q39095681-06486145-FF1E-46B9-A776-014C3325E4E9Q40496170-38AA4048-1B7C-4249-9C83-5B0DF43674A3Q41240124-9580ABD6-8E0C-47C3-884B-3C3E0005E236Q41494185-157D6CBE-5451-41AF-9AAC-5CAFA2188C1BQ41627465-83080540-91D6-4C66-9D47-7EFEC7775B8FQ42058494-814C3638-7DDA-49DE-A794-B718D395C04FQ42135508-873E2AA9-E6FD-4521-9CE5-321223D17B68Q42633454-3F52C006-5742-4EF8-800F-682049047C98Q47097822-CBA685FE-69E7-477B-A7C3-8C3BE4DB84C3Q47137765-C7DC5C20-4670-424A-B709-C4A3B996A4D4Q47144816-A4B9B159-F1CC-496C-B478-89D7155F0D34Q47291497-D19E3B9B-4173-41E9-8CBF-168AC05EE9D8Q47446325-CED9B462-9CA7-4403-9670-BD9CFCA8F47AQ48505268-845A84F3-7ED2-4F10-8A42-4B60E8B47F16Q50000036-C5B78576-AAD3-4254-B521-50F681209158Q50027789-0462CD13-D955-49F8-9CEB-A8F48F797469Q50091921-3C51C84B-4B79-409A-B60E-0A4447D771E7Q50903563-C045B2FA-9094-4CD8-BE77-1E033176E8DEQ52729623-17071FE0-B9F8-4143-A627-02182243CD89Q52729626-F7555ABE-9034-4E3A-ABFA-B018CDDC13DFQ53508391-42713DED-9AD6-4273-A1F8-AAAABAD63DF6Q55395762-9620281C-E55A-454D-A001-ADC626D47943Q57176905-1C42DA77-C143-4C32-B984-A7EEE3C82CB9Q57176906-D84A4D4F-AB87-4AD5-8A55-11379D569C6EQ57821546-9E6EE56D-91EA-4962-A3E4-21DE90506E06Q58599739-FEA865D0-94A2-464F-BD7E-BE548E509BFAQ58796976-6603AC72-295A-4FBA-926E-0329D5DC33F4
P2860
Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist fo
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Long-Term Outcome of Administr ...... of Endogenous Cells Persist fo
@ast
Long-Term Outcome of Administr ...... of Endogenous Cells Persist fo
@en
type
label
Long-Term Outcome of Administr ...... of Endogenous Cells Persist fo
@ast
Long-Term Outcome of Administr ...... of Endogenous Cells Persist fo
@en
prefLabel
Long-Term Outcome of Administr ...... of Endogenous Cells Persist fo
@ast
Long-Term Outcome of Administr ...... of Endogenous Cells Persist fo
@en
P2093
P2860
P1433
P1476
Long-Term Outcome of Administr ...... of Endogenous Cells Persist fo
@en
P2093
Gregg Rokosh
Heather Stowers
Qianhong Li
Qinghui Ou
Roberto Bolli
Santosh K Sanganalmath
Xian-Liang Tang
P2860
P304
P356
10.1161/CIRCRESAHA.115.307647
P577
2016-02-02T00:00:00Z